|By Marketwired .||
|July 3, 2014 11:21 AM EDT||
CENTER VALLEY, PA--(Marketwired - July 03, 2014) - Aesculap, Inc. is pleased to announce the availability of Lyoplant® Onlay, a biological, collagen based, absorbable dura substitution consisting of a bilayer membrane, designed to provide an elevated ease of use. The revolutionary product allows for a simple onlay application with the opportunity to incorporate suture fixation, if necessary.
- Helps protect against CSF leakage
- Excellent resorption rates
- Superior tensile strength,10x stronger than Suturable DuraGen*
- Strong biocompatibility
- Familiar use
- Time-saving onlay application
- Convenient handling
- Superior suture pull-out, 10x stronger than Suturable DuraGen*
- Multi-use: Onlay or Suturable
- 40% thinner than Suturable DuraGen*
- Excellent elasticity and flexibility
- Helps prevent cortical adhesion
Lyoplant Onlay is indicated as a dura substitute for the repair of the dura mater. To learn more about Lyoplant Onlay, visit aesculapusa.com/products/neurosurgery/dura-substitutesor contact your local Aesculap Sales Representative.
*Biomechanical data is on file at Aesculap, Inc. All testing results are based on averages. Tensile strength and suture retention testing were performed in a rehydrated state.
About Aesculap, Inc.
Aesculap, Inc., a B. Braun company, is part of a 175-year-old global organization focused on meeting the needs of an ever-changing healthcare community. Through close collaboration with its customers, Aesculap provides advanced technologies for general surgery, neurosurgery and closure technologies. Aesculap continues a proud heritage of leadership and responsiveness as we strive to deliver products and services that improve the quality of patients' lives. For more information, call 800-282-9000 or visit aesculapusa.com.
The following files are available for download:
Senior Project Manager - Corporate Communications